Adjuvant efficacy of nutrition support during pulmonary tuberculosis treating course
Citation: Si Z.L., Kang L.L., Shen X.B., et al. Adjuvant efficacy of nutrition support during pulmonary tuberculosis treating course: systematic review and meta-analysis. Chinese Medical Journal, 2015;128(23):3219-30
During anti‐TB course, nutrition support may be helpful in treatment of TB patients by improving both sputum smears or culture‐negative conversion rate and BMI, shortening the time of sputum conversion negative. Whether it can improve the final clinical effect, there still needs high‐level quality studies to confirm in the future.
TB can lead to nutrition deficiencies that may delay recovery. Nutritional support may encourage recovery in those being treated for TB. This study aimed to assess the effectiveness of nutrition support on promoting the recovery of adult pulmonary TB patients with anti‐TB drug therapy. Nineteen studies were included in the review. The authors concluded that nutrition support may be helpful in treatment of TB patients. Evidence came from measuring sputum smears- or culture-negative conversion rate. The authors acknowledged the likely presence of language bias, publication bias and the heterogeneity of the results dependent on how long support was provided.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.